Recombinant Human Growth Hormone (rhGH) is a well-established biopharmaceutical widely used in the treatment of growth hormone deficiency and related disorders. As global demand for biologics continues to rise, rhGH remains a key product in both innovator and biosimilar markets.
For pharmaceutical manufacturers, sourcing high-quality rhGH API is critical to ensuring product efficacy, safety, and regulatory compliance.